Kemperman H - Search Results

1

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. de Jong E, et al. Among authors: kemperman h. Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2. Lancet Infect Dis. 2016. PMID: 26947523 Clinical Trial.

2

Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa.

Hyseni A, Kemperman H, de Lange DW, de Groot PG, Linssen M, Kesecioglu J, Lisman T, Roest M. Hyseni A, et al. Among authors: kemperman h. J Thromb Haemost. 2013 Dec;11(12):2111-7. doi: 10.1111/jth.12427. J Thromb Haemost. 2013. PMID: 24131789 Free article.

3

Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome.

Hyseni A, Kemperman H, de Lange DW, Kesecioglu J, de Groot PG, Roest M. Hyseni A, et al. Among authors: kemperman h. Blood. 2014 Apr 3;123(14):2153-6. doi: 10.1182/blood-2013-08-508093. Epub 2014 Jan 23. Blood. 2014. PMID: 24458436 Free article.

4

Baseline thrombospondin-1 concentrations are not associated with mortality in septic patients: a single-center cohort study on the intensive care unit.

van der Wekken RJ, Kemperman H, Roest M, de Lange DW. van der Wekken RJ, et al. Among authors: kemperman h. Intensive Care Med Exp. 2017 Dec;5(1):7. doi: 10.1186/s40635-017-0120-y. Epub 2017 Jan 25. Intensive Care Med Exp. 2017. PMID: 28124196 Free PMC article.

5

Soluble P-selectin as a Biomarker for Infection and Survival in Patients With a Systemic Inflammatory Response Syndrome on the Intensive Care Unit.

Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW. Schrijver IT, et al. Among authors: kemperman h. Biomark Insights. 2017 Feb 7;12:1177271916684823. doi: 10.1177/1177271916684823. eCollection 2017. Biomark Insights. 2017. PMID: 28469394 Free PMC article.

6

Myeloperoxidase can differentiate between sepsis and non-infectious SIRS and predicts mortality in intensive care patients with SIRS.

Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW. Schrijver IT, et al. Among authors: kemperman h. Intensive Care Med Exp. 2017 Sep 15;5(1):43. doi: 10.1186/s40635-017-0157-y. Intensive Care Med Exp. 2017. PMID: 28916973 Free PMC article.

7

Osteoprotegerin is Higher in Sepsis Than in Noninfectious SIRS and Predicts 30-Day Mortality of SIRS Patients in the Intensive Care.

Kemperman H, Schrijver IT, Roest M, Kesecioglu J, van Solinge WW, de Lange DW. Kemperman H, et al. J Appl Lab Med. 2019 Jan;3(4):559-568. doi: 10.1373/jalm.2018.026559. Epub 2018 Jul 16. J Appl Lab Med. 2019. PMID: 31639725 Free article.

8

Diagnostic Accuracy of Procalcitonin and C-reactive Protein Is Insufficient to Predict Proven Infection: A Retrospective Cohort Study in Critically Ill Patients Fulfilling the Sepsis-3 Criteria.

van Oers JAH, de Jong E, Kemperman H, Girbes ARJ, de Lange DW. van Oers JAH, et al. Among authors: kemperman h. J Appl Lab Med. 2020 Jan 1;5(1):62-72. doi: 10.1373/jalm.2019.029777. J Appl Lab Med. 2020. PMID: 31811071 Free article.

9

Beta-2-glycoprotein I as a biomarker for sepsis in critically ill patients in the intensive care unit: a prospective cohort study.

Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW. Schrijver IT, et al. Among authors: kemperman h. Crit Care. 2020 Jun 15;24(1):341. doi: 10.1186/s13054-020-03066-3. Crit Care. 2020. PMID: 32539745 Free PMC article. No abstract available.

10

Aldosterone, atherosclerosis and vascular events in patients with stable coronary artery disease.

Hillaert MA, Lentjes EG, Kemperman H, van der Graaf Y, Nathoe HM, Beygui F, Montalescot G, Doevendans PA, Wassink AM, van Belle E; SMART Study Group. Hillaert MA, et al. Among authors: kemperman h. Int J Cardiol. 2013 Sep 1;167(5):1929-35. doi: 10.1016/j.ijcard.2012.05.034. Epub 2012 Jun 23. Int J Cardiol. 2013. PMID: 22727970 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page